"""
    HospitalFinanceToolbox Research Framework

A comprehensive research and analysis toolkit for healthcare economics,
built for exploring economic questions across clinical, organizational,
and policy domains.

This framework supports:
- Cost-effectiveness analysis (CEA) research
- Health economic evaluation studies
- Hospital financial impact modeling
- Intervention ROI and value analysis
- Policy scenario testing
- Comparative effectiveness research
- Budget impact modeling
- Real-world data analysis

Research Workflows Supported:
1. Study Design & Protocol Development
2. Data Collection & Preparation
3. Cost & Outcome Analysis
4. Statistical Analysis & Sensitivity
5. Results Visualization & Reporting
6. Publication Preparation
"""

# ═══════════════════════════════════════════════════════════════
# RESEARCH ANALYSIS TEMPLATES
# ═══════════════════════════════════════════════════════════════

## Template 1: Economic Evaluation Study Protocol

template_cea_protocol = """
# Cost-Effectiveness Analysis Study Protocol

## Research Question
- What is the incremental cost-effectiveness of [Intervention] vs [Comparator]?
- What is the cost per QALY gained?
- Is the intervention cost-effective at [Threshold]?

## Study Design
- Type: [RCT / Cohort / Markov / Simulation]
- Perspective: [Healthcare system / Societal / Payer]
- Time horizon: [1 year / 5 years / Lifetime]
- Discount rate: [3% / 3.5% / Custom]

## Population
- Inclusion criteria: [...]
- Exclusion criteria: [...]
- Baseline characteristics: [...]

## Intervention
- Description: [...]
- Implementation: [...]
- Costs: [Training, Equipment, Personnel, Maintenance]

## Comparator
- Standard care or [Alternative intervention]
- Current practice in [Setting]

## Outcomes
Primary:
- Cost (all-cause healthcare)
- QALYs (from [Utility source])
- ICER (Incremental Cost-Effectiveness Ratio)

Secondary:
- Cost per case prevented
- Budget impact
- Sensitivity analysis
- Cost-effectiveness acceptability curve

## Analysis Plan
1. Base case analysis (deterministic)
2. Sensitivity analysis (±10-20% on key parameters)
3. Probabilistic sensitivity analysis (Monte Carlo)
4. Scenario analysis (best/worst case)
5. Subgroup analysis (if applicable)

## Statistical Methods
- [Describe analysis approach]
- Software: Julia + HospitalFinanceToolbox
- [Significance level, confidence intervals]

## Health Economic Methodology
- Utility measurement: [EQ-5D / Visual Analogue Scale / Time Trade-Off]
- Cost measurement: [Micro-costing / Top-down / Hybrid]
- Valuation: [Willingness-to-pay / Cost-utility threshold]

## Decision Rule
Intervention is recommended if ICER < [Threshold] per QALY

## Expected Outputs
- CEA cost-effectiveness plane plot
- Cost-effectiveness acceptability curve (CEAC)
- Sensitivity tornado diagram
- Decision tree analysis
- Tables of results by subgroup
"""

## Template 2: Research Data Analysis Workflow

template_analysis_workflow = """
# Research Data Analysis Workflow

## Phase 1: Data Preparation
- Source: [EHR / Claims / Billing / Survey]
- Time period: [Dates]
- Cohort: [N patients]
- Inclusion/exclusion: [Criteria]

## Phase 2: Cohort Characterization
- Demographics: Age, sex, comorbidities
- Clinical: Diagnoses, severity, procedures
- Economic: Payer mix, insurance status
- Baseline differences: [Statistical tests]

## Phase 3: Cost Analysis
- Cost identification: [Direct / Indirect / Intangible]
- Cost measurement: [Item-level / Department-level]
- Cost allocation: [Proportional / Activity-based]
- Sensitivity: [±10-20% ranges]

## Phase 4: Outcome Analysis
- Clinical outcomes: [Mortality / Morbidity / Readmission]
- Patient-reported outcomes: [Quality of life / Satisfaction]
- Quality metrics: [Safety / Effectiveness / Patient-centeredness]

## Phase 5: Economic Analysis
- Cost-effectiveness: ICER calculation
- Budget impact: 3-year projection
- Return on investment: Cost vs. benefit
- Break-even analysis: Required improvement

## Phase 6: Sensitivity & Uncertainty
- Univariate sensitivity: Parameter ranges
- Probabilistic: Monte Carlo simulation
- Threshold analysis: Critical decision points
- Tornado diagram: Parameter importance

## Phase 7: Interpretation & Reporting
- Main findings: Cost, effect, ICER
- Clinical significance: Beyond statistics
- Generalizability: Internal/external validity
- Implications: Policy, practice, research
"""

## Template 3: Hospital Intervention Evaluation

template_hospital_intervention = """
# Hospital Quality/Safety Intervention Evaluation

## Intervention Description
- Name: [E.g., "Sepsis Alert Protocol"]
- Target: [Patient population / Condition]
- Setting: [ICU / ED / General ward / Hospital-wide]
- Duration: [Implementation period]
- Cost: [Direct costs to implement]

## Current Practice (Baseline)
- Process: [How currently managed]
- Outcomes: [Current rates of adverse events]
- Cost: [Current cost per patient]
- Compliance: [Current adherence to guidelines]

## Proposed Intervention
- Key components: [Specific changes]
- Expected mechanism: [How it reduces harm/cost]
- Success metrics: [Measurable targets]
- Resource requirements: [Staff, training, technology]

## Economic Impact Analysis

### Costs
- Implementation:
  * Training: [X hours × Y staff × Z rate]
  * Technology: [Software, hardware, licenses]
  * Change management: [Consulting, communication]
- Ongoing:
  * Maintenance: [Annual support]
  * Monitoring: [QA resources]
  * Updates: [Continuous improvement]

### Benefits (Cost Savings + Quality Gains)
- Prevented outcomes:
  * [Complication] prevention: [X% reduction] × [Cost/case]
  * [Mortality] reduction: [X lives] × [Cost/death]
  * [Readmission] reduction: [X cases] × [Cost/readmit]
- QALYs gained: [From outcome prevention]
- Revenue impact: [From quality bonuses / penalties]

### Financial Analysis
- Break-even point: [Months to recover implementation costs]
- ROI: [Cost savings / Implementation cost]
- NPV (3-year): [Net present value]
- Budget impact: [Year 1, 2, 3 impact]

## Research Questions
1. What is the effectiveness of the intervention?
2. What is the cost-effectiveness (cost per outcome prevented)?
3. What is the return on investment?
4. How does it vary by patient subgroup?
5. What are the barriers to implementation?
6. What is required for sustainability?

## Study Design Options
- Pre-post comparison with historical controls
- Matched cohort analysis
- Interrupted time series
- Randomized trial (if feasible)
- Simulation-based projections
"""

## Template 4: Real-World Data Analysis

template_rwd_analysis = """
# Real-World Data (RWD) Healthcare Economics Analysis

## Data Source
- Source: [EHR / Claims / Registry / Combination]
- Time period: [Years]
- Sample size: [N patients, N episodes]
- Representativeness: [Describe population]

## Research Question
- Effectiveness: What outcomes occur in real practice?
- Safety: What are adverse event rates?
- Economics: What are real-world costs?
- Equity: How do outcomes vary by demographic group?

## Cohort Definition
- Inclusion: [Age, diagnosis, treatment, follow-up]
- Exclusion: [Missing data, lost to follow-up, etc.]
- Time windows: [Observation periods]
- Stratification: [By provider, setting, time period]

## Variables & Measurements

### Clinical/Outcome Variables
- Primary outcome: [Measure, timing, definition]
- Secondary outcomes: [Additional measures]
- Confounders: [To control in analysis]
- Covariates: [For adjustment]

### Economic Variables
- Costs: [Direct medical, indirect, total cost of care]
- Components: [Hospitalization, ED, outpatient, medications]
- Time periods: [Pre-intervention, intervention, follow-up]
- Payer perspective: [Medicare, Medicaid, Commercial, All]

### Quality/Process Variables
- Adherence: [To clinical guidelines]
- Quality: [Process measures, outcome measures]
- Safety: [Adverse events, incidents]
- Patient experience: [Satisfaction, engagement]

## Analysis Approach

### Descriptive
- Cohort characteristics: [Demographics, clinical, economic]
- Outcome frequencies: [Rates, percentages, means]
- Cost distributions: [Mean, median, range]
- Temporal trends: [Over study period]

### Comparative
- Comparison groups: [Intervention vs. standard care]
- Statistical tests: [T-tests, chi-square, logistic regression]
- Adjustment: [Propensity score, regression, matching]
- Subgroup analysis: [By demographics, severity, setting]

### Economic
- Cost analysis: [Mean costs by group]
- Cost-effectiveness: [ICER, cost per outcome]
- Budget impact: [Total costs to system]
- ROI: [Cost-benefit ratio]

## Real-World Considerations
- Data completeness: [Missing data strategy]
- Coding accuracy: [Validation of diagnoses/procedures]
- Selection bias: [How representativeness assessed]
- Confounding: [Residual confounding discussion]
- Generalizability: [Limitations and strengths]

## Outputs & Dissemination
- Primary manuscript: [Cost-effectiveness results]
- Secondary analyses: [Subgroup, sensitivity]
- Clinical summary: [For provider audience]
- Policy brief: [For payers/administrators]
- Open science: [Code + de-identified data]
"""

## Template 5: Policy Scenario Analysis

template_policy_scenario = """
# Policy Scenario Analysis for Healthcare Economics

## Policy Question
- Impact of [Policy change] on [Outcome]
- Example: "What is the impact of capitation vs. FFS on intervention adoption?"

## Current Policy/Status Quo
- Payment model: [FFS / Capitation / VBC / Bundled]
- Incentives: [Quality bonuses / Penalties / Risk-sharing]
- Constraints: [Regulations / Coverage decisions / Access barriers]
- Financial impact: [Annual costs to system]

## Proposed Policy Change
- Description: [Specific change to payment/regulation]
- Effective date: [Implementation timeline]
- Target population: [Who affected]
- Expected mechanism: [How it changes behavior/outcomes]

## Scenario Modeling

### Scenario 1: Base Case (Status Quo)
- Payment rates: [Current]
- Utilization: [Current patterns]
- Outcomes: [Current]
- Cost: [Baseline cost]

### Scenario 2: Proposed Policy
- Payment rates: [Proposed changes]
- Utilization: [Expected changes from incentives]
- Outcomes: [Expected improvements]
- Cost: [Projected cost]

### Scenario 3: Alternative 1
- [Different policy variation]
- [Expected impact]

### Scenario 4: Alternative 2
- [Another policy variation]
- [Expected impact]

## Economic Impact Analysis
- Net cost change: [By payer, by provider, by patient]
- Cost-effectiveness: [Per unit outcome]
- Distribution: [Who benefits, who bears costs]
- Sustainability: [Long-term financial impact]

## Sensitivity & Uncertainty
- Key assumptions: [List major assumptions]
- Sensitivity ranges: [±10-30% on key parameters]
- Threshold analysis: [At what parameter values does decision change?]
- Robustness: [Results under alternative scenarios]

## Implementation Considerations
- Barriers: [What prevents adoption]
- Facilitators: [What enables success]
- Timeline: [Phased implementation]
- Monitoring: [Metrics to track impact]
- Adjustment: [How to modify if outcomes differ]

## Research Questions
1. What is the economic impact of the proposed policy?
2. How does it affect different populations differently?
3. What are the unintended consequences?
4. How does it compare to alternative policies?
5. Is it sustainable long-term?
"""

# ═══════════════════════════════════════════════════════════════
# RESEARCH DATASETS & CASE STUDIES
# ═══════════════════════════════════════════════════════════════

## Case Study 1: Rural Hospital Network Economics

case_study_rural_network = """
# Research Case Study: Rural Hospital Network Economics

## Research Context
- Setting: 12-hospital rural network, 5-state region
- Population served: 500,000 (60% rural, 40% small city)
- Economic challenge: Declining reimbursement, rising costs
- Key question: How can rural hospitals remain viable while improving quality?

## Research Goals
1. Quantify current financial sustainability of each hospital
2. Identify high-impact cost reduction opportunities
3. Model impact of proposed service line changes
4. Project 5-year financial outlook under different scenarios
5. Identify prerequisite capacity-building investments

## Analysis Components

### 1. Current State Financial Analysis
- Cost reports (CMS 2552-10): Federal payment adequacy
- Service line profitability: Which services lose/make money
- Payer mix impact: Medicare, Medicaid, Commercial, Uninsured
- Cost structure: Fixed vs. variable, clinical vs. administrative
- Benchmark comparison: How this network compares to peers

### 2. Cost Reduction Opportunity Analysis
- Labor costs: Staffing models, productivity benchmarks
- Procurement: Contracting leverage, supply chain optimization
- Utilization: Unnecessary tests/procedures, variation reduction
- Readmissions: Prevention programs, quality improvements
- Operational efficiency: Workflows, technology adoption

### 3. Service Line Strategy Analysis
- Current portfolio: Profitability, quality, market position
- Consolidation scenarios: Close services vs. regional partnerships
- Expansion scenarios: Grow high-margin, high-need services
- Financial impact: Revenue, cost, net margin
- Quality/Access impact: How patients affected

### 4. Value-Based Care Transition
- Current: FFS baseline economics
- Target: Capitated, shared-savings, quality-based
- Transition pathway: Phased approach
- Financial impact: Year-by-year projections
- Success metrics: Quality, cost, QALY outcomes

### 5. Sustainability Modeling
- Base case: Continue current model
- Cost reduction: Implement efficiency improvements
- Care redesign: Evidence-based interventions
- Clinical outcomes: How financial and quality changes interact
- Break-even analysis: What's required for viability

## Expected Research Outputs
- Peer-reviewed publication: "Financial Sustainability of Rural Hospital Networks"
- Policy brief: For state health department
- Executive summary: For hospital board/leadership
- Technical appendix: Methods, data sources, sensitivity analysis
- Open-source analysis: Code + deidentified data for research community
"""

# ═══════════════════════════════════════════════════════════════
# RESEARCH COLLABORATION AREAS
# ═══════════════════════════════════════════════════════════════

research_collaboration_areas = """
# Potential Research Collaboration Areas

## Clinical Domains

### Neonatal/Pediatric Healthcare Economics
- Cost-effectiveness of perinatal interventions (surfactant, CPAP, antibiotics)
- Physiological modeling + economics (PedNeoSim integration)
- Quality-adjusted survival analysis
- Readmission prevention ROI

### Rural Hospital Economics
- Financial sustainability of Critical Access Hospitals
- Integration with RuralHospitalSim for comprehensive analysis
- Service line profitability analysis
- Quality-value-cost tradeoffs

### Chronic Disease Management
- Preventive care value propositions (hypertension, diabetes)
- Long-term cost-effectiveness
- Patient population health impact
- Regional variation analysis

### Emergency Medicine Economics
- ED efficiency and cost-effectiveness
- Triage protocols and resource allocation
- Acute intervention ROI
- Readmission prevention from ED

## Research Methodologies

### Real-World Data Analysis
- EHR-based cost-effectiveness studies
- Claims data analysis for population-level economics
- Registry-based comparative effectiveness
- Quality improvement analytics

### Simulation Modeling
- Disease progression (Markov models)
- Patient flow (discrete-event simulation)
- System dynamics (healthcare system behavior)
- Agent-based modeling (population-level)

### Machine Learning for Economics
- Cost prediction (high-cost patient identification)
- Risk stratification for interventions
- Outcome prediction for value assessment
- Pattern recognition in healthcare utilization

## Policy Research Areas

### Payment Model Analysis
- Fee-for-service baseline modeling
- Value-based care transitions
- Bundled payment design
- Risk-sharing arrangements

### Healthcare Equity
- Cost-effectiveness by demographic group
- Access and utilization disparities
- Health outcome variation
- Intervention cost-effectiveness heterogeneity

### Pandemic/Crisis Economics
- Healthcare system surge capacity economics
- Emergency resource allocation
- Cost of delay in treatment
- Long-term financial recovery
"""

# ═══════════════════════════════════════════════════════════════
# RESEARCH OUTPUT TYPES & PUBLICATION PATHWAYS
# ═══════════════════════════════════════════════════════════════

publication_pathways = """
# Research Output Types & Publication Pathways

## Peer-Reviewed Publications

### Health Economics Journals
- Health Economics
- Medical Decision Making
- Cost Effectiveness and Resource Allocation
- PharmacoEconomics
- Value in Health

### Clinical/Specialty Journals
- Pediatrics (neonatal economics)
- American Journal of Surgery (hospital economics)
- Medical Care (rural health)
- JAMA Health Forum (policy)
- Health Services Research (methodology)

### Methods/Open Science
- JAMA Open
- PLOS Medicine
- PLOS ONE (methods)
- Scientific Reports
- Research Integrity

## Grey Literature & Technical Reports

### Policy & Practice
- State health department reports
- Hospital association briefs
- CDC/CMS analyses
- Regional quality consortium reports

### Technical Documentation
- Research protocols
- Data documentation
- Code repositories (GitHub)
- Supplementary materials

## Conference Presentations

### Health Economics Conferences
- ISPOR (International Society for Pharmacoeconomics and Outcomes Research)
- APHA (American Public Health Association)
- AcademyHealth (healthcare research & policy)
- AAHC (Association of Academic Health Centers)

### Clinical Specialty Conferences
- American Academy of Pediatrics (AAP)
- American Surgical Association
- American College of Surgeons
- Society for Hospital Medicine

## Data & Code Sharing

### Open Science Practices
- GitHub repositories with code
- Zenodo for datasets (if deidentified)
- OSF (Open Science Framework) for protocols
- Data papers describing datasets
- Preprints (medRxiv, arXiv)

## Public Engagement

### Webinars & Training
- Journal club presentations
- Hospital leadership briefings
- Payer/CMS educational sessions
- Healthcare provider training

### Lay Summaries
- Healthcare provider briefs
- Patient-friendly summaries
- Policy maker fact sheets
- Media/public communication
"""
